PR Newswire Clinical TrialsOriginal article
PARADIGM HEALTH SUBMITS RESPONSE TO FDA'S REAL-TIME CLINICAL TRIALS INITIATIVE RFI, INFORMED BY BIOPHARMA SPONSORS AND PROVIDERS
RegulatoryNeutral
AI Analysis
Summary
Paradigm Health submitted its response to the FDA's Request for Information regarding the Real-Time Clinical Trials initiative, for which it serves as the sole technology provider operationalizing the proof-of-concept studies.
Outcome Details
Submission of response to FDA's Real-Time Clinical Trials Initiative RFI
Importance:3/10
Sentiment:
0.00
FDAreal-time clinical trialsregulatory submissionRFI responsetechnology provider
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on June 30, 2026 5:44 PM